Natural history of inhalation melioidosis in rhesus macaques (Macaca mulatta) and African green monkeys (Chlorocebus aethiops)

Infection and Immunity

Volumn 80, Issue 9, 2012, Pages 3332-3340

  Yeager, John J ^a   Facemire, Paul ^a   Dabisch, Paul A ^a   Robinson, Camenzind G ^a   Nyakiti, David ^a   Beck, Katie ^b   Baker, Reese ^a   Pitt, M Louise M ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b Ke'Aki Technologies LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHOPNEUMONIA; BURKHOLDERIA PSEUDOMALLEI; CHLOROCEBUS; DYSPNEA; FEMALE; LEUKOCYTOSIS; MALE; MELIOIDOSIS; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY;

ANIMALS; BRONCHOPNEUMONIA; BURKHOLDERIA PSEUDOMALLEI; CERCOPITHECUS AETHIOPS; CYTOKINES; DISEASE MODELS, ANIMAL; LUNG; MACACA MULATTA; MALE; MELIOIDOSIS;

EID: 84867585955     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00675-12     Document Type: Article

References (43)

1. Butler TM, Schmidt RE, Wiley GL. 1971. Melioidosis in a chimpanzee. Am. J. Vet. Res. 32:1109-1117.
2. Cheng AC. 2010. Melioidosis: advances in diagnosis and treatment. Curr. Opin. Infect. Dis. 23:554-559.
3. Cheng AC, Currie BJ. 2005. Melioidosis: epidemiology, pathophysiology, and management. Clin. Microbiol. Rev. 18:383-426.
4. Chierakul W, et al. 2005. Melioidosis in 6 tsunami survivors in Southern Thailand. Clin. Infect. Dis. 42:982-990.
5. Chin C-Y, Monack DM, Nathan S. 2010. Genome-wide transcriptome profiling of a murine acute melioidosis model reveals new insights into how Burkholderia pseudomallei overcomes host innate immunity. BMC Genomics 11:672.
6. Currie BJ, Fisher DA, Howard DM, Burrow JNC. 2000. Neurological melioidosis. Acta Trop. 74:145-151.
7. Currie BJ, Dance DAB, Cheng AC. 2008. The global distribution of Burkholderia pseudomallei and melioidosis: an update. Trans. R. Soc. Trop. Med. Hyg. 102(Suppl 1):S1-S4.
8. Currie BJ, Jacups SP. 2003. Intensity of rainfall and severity of melioidosis, Australia. Emerg. Infect. Dis. 9:1538-1542.
9. Currie BJ, Ward L, Cheng AC. 2010. The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl. Trop. Dis. 4:e900. doi:10.1371/journal.pntd.0000900.
10. Dabisch PA, Kline J, Lewis C, Yeager J, Pitt MLM. 2010. Characterization of a head-only aerosol exposure system for nonhuman primates. Inhal. Toxicol. 22:224-233.
11. Dance DAB. 1991. Melioidosis: the tip of the iceberg? Clin. Microbiol. Rev. 4:52-60.
12. DeShazer D, Brett PJ, Carlyon R, Woods DE. 1997. Mutagenesis of Burkholderia pseudomallei with Tn5-OT182: isolation of motility mutants and molecular characterization of the flagellin structural gene. J. Bacteriol. 179:2116-2125.
13. Easton A, Haque A, Chu K, Lukaszewski RA, Bancroft GJ. 2007. A critical role for neutrophils in resistance to experimental infection with Burkholderia pseudomallei. J. Infect. Dis. 195:99-107.
14. Fritz PE, Miller JG, Slayter M, Smith TJ. 1986. Naturally occurring melioidosis in a colonized rhesus monkey (Macaca mulatta). Lab. Anim. 20:281-285.
15. Hartings JM, Roy CJ. 2004. The automated bioaerosol exposure system: preclinical platform development and a respiratory dosimetry application with nonhuman primates. J. Pharmacol. Toxicol. Methods 49:39-55.
16. Hii C-S, et al. 2008. Interleukin-8 induction by Burkholderia pseudomallei can occur without Toll-like receptor signaling but requires a functional type III secretion system. J. Infect. Dis. 197:1537-1547.
17. Howe C, Sampath A, Spotniz M. 1971. The Pseudomallei group: a review. J. Infect. Dis. 124:598-606.
18. Inglis TJJ, Rolim DB, Sousa ADQ. 2006. Melioidosis in the Americas. Am. J. Trop. Med. Hyg. 75:947-954.
19. Jeddeloh JA, Fritz DL, Waag DM, Hartings JM, Andrews GP. 2003. Biodefense-driven murine model of pneumonic melioidosis. Infect. Immun. 71:584-587.
20. Kaufmann AD, et al. 1970. Melioidosis in imported primates nonhuman. J. Wildl. Dis. 6:211-219.
21. Laws TR, Smither SJ, Lukaszewski RA, Atkins HS. 2011. Neutrophils are the predominant cell-type to associate with Burkholderia pseudomallei in a BALB/c mouse model of respiratory melioidosis. Microb. Pathog. 51:471-475.
22. Lazar Adler NR, et al. 2009. The molecular and cellular basis of pathogenesis in melioidosis: how does Burkholderia pseudomallei cause disease? FEMS Microbiol. Rev. 33:1079-1099.
23. Lever MS, Nelson M, Stagg AJ, Beedham RJ, Simpson AJH. 2009. Experimental acute respiratory Burkholderia pseudomallei infection in BALB/c mice. Int. J. Exp. Pathol. 90:16-25.
24. Limmathurotsakul D, et al. 2010. Increasing incidence of human melioidosis in Northeast Thailand. Am. J. Trop. Med. Hyg. 82:1113-1117.
25. Limmathurotsakul D, et al. 2011. Repeat blood culture positive for B. pseudomallei indicates an increased risk of death from melioidosis. Am. J. Trop. Med. Hyg. 84:858-861.
26. Loveleena Chaudhry R, Dhawan B. 2004. Melioidosis; the remarkable imitator: recent perspectives. J. Assoc. Physicians India 52:417-420.
27. Manzenuik IN, et al. 1999. Burkholderia mallei and Burkholderia pseudomallei. Study of immuno-and pathogenesis of malleus and melloidosis. Antibiot. Khimioter. 4:21-26.
28. Miller WR, Pannell L, Cravitz L, Tanner WA, Rosebury T. 1948. Studies on certain biological characteristics of Maleomyces mallei and Malleomyces pseuduomallei II. Virulence and infectivity for animals. J. Bacteriol. 55: 127-135.
29. National Research Council. 2011. Guide for the care and use of laboratory animals, 8th ed. National Academies Press, Washington, DC.
30. Nelson M, et al. 2011. Development of an acute model of inhalational melioidosis in the common marmoset (Callithrix jacchus). Int. J. Exp. Pathol. 92:428-435.
31. Owen SJ, et al. 2009. Nasal-associated lymphoid tissue and olfactory epithelium as portals of entry for Burkholderia pseudomallei in murine melioidosis. J. Infect. Dis. 199:1761-1770.
32. Parameswaran U, Baird R, Ward L, Currie BJ. 2012. Melioidosis at Royal Darwin Hospital in the big 2009-2010 wet season: comparison with the preceding 20 years. Med. J. Aust. 10:345-348.
33. Piggott J, Hochholzer L. 1970. Human melioidosis: a histopathologic study of acute and chronic melioidosis. Arch. Pathol. 90:101-111.
34. Rammaert B, et al. 2011. Pulmonary melioidosis in Cambodia: a prospective study. BMC Infect. Dis. 11:126.
35. Saravu K, et al. 2008. Melioidosis-a case series from south India. Trans. R. Soc. Trop. Med. Hyg. 102:S18-S20.
36. Tan G-YG, et al. 2008. Burkholderia pseudomallei aerosol infection results in differential inflammatory responses in BALB/c and C57Bl/6 mice. J Med. Microbiol. 57:508-515.
37. Treviño SR, et al. 2006. Monoclonal antibodies passively protect BALB/c mice against Burkholderia mallei aerosol challenge. Infect. Immun. 74: 1958-1961.
38. Ulett GC, Ketheesan N, Hirst RG. 2000. Cytokine gene expression in innately susceptible BALB/c mice and relatively resistant C57BL/6 mice during infection with virulent Burkholderia pseudomallei. Infect. Immun. 68:2034-2042.
39. Warawa JM. 2010. Evaluation of surrogate animal models of melioidosis. Front. Microbiol. 1:141.
40. White NJ. 2003. Melioidosis. Lancet 361:1715-1722.
41. Wiersinga WJ, et al. 2008. Activation of coagulation with concurrent impairment of anticoagulant mechanisms correlates with a poor outcome in severe melioidosis. J. Thromb. Haemost. 6:32-39.
42. Wiersinga WJ, et al. 2007. High-throughput mRNA profiling characterizes the expression of inflammatory molecules in sepsis caused by Burkholderia pseudomallei. Infect. Immun. 75:3074-3079.
43. Wiersinga WJ, van der Poll T. 2009. Immunity to Burkholderia pseudomallei. Curr. Opin. Infect. Dis. 22:102-108.